Cwm LLC Boosts Stake in Amedisys, Inc. (NASDAQ:AMED)

Cwm LLC boosted its stake in shares of Amedisys, Inc. (NASDAQ:AMED) by 40.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,629 shares of the health services provider’s stock after acquiring an additional 757 shares during the quarter. Cwm LLC’s holdings in Amedisys were worth $250,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in AMED. Pentwater Capital Management LP increased its stake in Amedisys by 239.5% during the third quarter. Pentwater Capital Management LP now owns 1,144,000 shares of the health services provider’s stock worth $106,850,000 after acquiring an additional 807,000 shares during the last quarter. Westchester Capital Management LLC increased its stake in Amedisys by 269.7% during the third quarter. Westchester Capital Management LLC now owns 850,386 shares of the health services provider’s stock worth $79,426,000 after acquiring an additional 620,386 shares during the last quarter. Alpine Associates Management Inc. increased its stake in Amedisys by 46.6% during the third quarter. Alpine Associates Management Inc. now owns 1,033,497 shares of the health services provider’s stock worth $96,529,000 after acquiring an additional 328,300 shares during the last quarter. Bank of Nova Scotia bought a new stake in Amedisys during the third quarter worth approximately $26,671,000. Finally, AQR Arbitrage LLC grew its stake in shares of Amedisys by 407.7% during the third quarter. AQR Arbitrage LLC now owns 314,321 shares of the health services provider’s stock valued at $29,358,000 after buying an additional 252,405 shares during the last quarter. 94.36% of the stock is owned by institutional investors.

Amedisys Stock Down 0.4 %

Shares of NASDAQ AMED opened at $92.08 on Friday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.09 and a current ratio of 1.09. The firm has a market capitalization of $3.01 billion, a price-to-earnings ratio of -143.88, a PEG ratio of 3.42 and a beta of 0.84. The stock has a 50 day moving average price of $92.40 and a 200 day moving average price of $93.33. Amedisys, Inc. has a 52-week low of $73.10 and a 52-week high of $96.44.

Amedisys (NASDAQ:AMED) last announced its quarterly earnings results on Wednesday, April 24th. The health services provider reported $1.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.02 by $0.01. The firm had revenue of $571.41 million during the quarter, compared to analyst estimates of $565.38 million. Amedisys had a positive return on equity of 12.85% and a negative net margin of 0.91%. Amedisys’s quarterly revenue was up 2.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.00 earnings per share. Sell-side analysts expect that Amedisys, Inc. will post 4.57 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Royal Bank of Canada upped their target price on Amedisys from $97.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, March 25th. Raymond James reaffirmed a “market perform” rating on shares of Amedisys in a research note on Tuesday, March 26th. StockNews.com raised Amedisys from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and set a $101.00 target price on shares of Amedisys in a research note on Thursday, April 25th. Seven analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, Amedisys has a consensus rating of “Hold” and an average price target of $97.50.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.